Traded Oct 31, 2025 · filed 3 days later
Routine share withholding; mechanical by default.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director purchased ~$99K of HAE shares in the open market
Traded Nov 10, 2025 · Filed Nov 12, 2025
- ~$99K
- Approx. value · 1,400 sh @ $70.56
- 25K
- Holds after · shares reported
- +48.5%
- stock since the trade · S&P 500 +13.7%, $70.48 → $104.68 on Oct 5
Why it stands out
A Haemonetics director paid $99K out of pocket for Haemonetics shares. The Haemonetics shares held grew by 6%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Nov 10, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Nov 12, 2025
Director$25K–$100KHoldings +6%
Context
- Classification
open market purchase
Code P — open-market or private purchase
- Absolute commitment
~$98,784
Shares × reported transaction price
- Size band
$25K–$100K
- Ownership change
+6.0%
Purchase shares ÷ estimated pre-transaction holdings, from the filing